Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Gut Microbiome Composition As a Prognostic Marker in CD19-Targeting CAR T-Cell Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Seok Jin Kim, SangEun Yoon, Woorim Kang, Mauricio Chalita, Hong Hoe Koo, Dong-Wook Hyun, Hyun Kim, Junhun Cho, Won Seog Kim

Blood (2024) 144 (Supplement 1): 1595.

https://doi.org/10.1182/blood-2024-205074

Published: 2024

Journal Articles

Real-World Outcomes of Polatuzumab Vedotin with Bendamustine and Rituximab As Salvage and Bridge Therapy to CAR T-Cell Treatment in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Changgon Kim, SangEun Yoon, Hyun-Young Kim, Duck Cho, Hong Hoe Koo, Junhun Cho, Won Seog Kim, Seok Jin Kim

Blood (2024) 144 (Supplement 1): 3107.

https://doi.org/10.1182/blood-2024-204987

Published: 2024

Journal Articles

Long-Term Outcomes of Bronchus-Associated Lymphoid Tissue Lymphoma Based on Lung Involvement Status: A Single-Center Real-World Data Analysis in Korea

Changgon Kim, Seok Jin Kim, Won Seog Kim, SangEun Yoon

Blood (2024) 144 (Supplement 1): 6309.

https://doi.org/10.1182/blood-2024-206547

Published: 2024

Journal Articles

New Diagnostic Technology for the Isolation and Analysis of Live Myeloma Cell from the Blood of Multiple Myeloma Patients

Hoin Kang, Jihyun Lee, Soee Kim, Ju Bi Lee, Hyo Yong Kim, Min Hyung Kim, Hyeonji Cho, SangEun Yoon, Kihyun Kim, Jungwon Kim

Blood (2024) 144 (Supplement 1): 7480.

https://doi.org/10.1182/blood-2024-198545

Published: 2024

Journal Articles

Multicenter, Open-Label, Phase I Study of Azacitidine-CHOP for Patients with Nodal T-Cell Lymphoma with T-Follicular Helper Phenotype

Seok Jin Kim, SangEun Yoon, Ji Hyun Lee, Jeong-Ok Lee, Seong Hyun Jeong, Sung-Nam Lim, Ho-Jin Shin, Duck Hwan Yang, Won Seog Kim

Blood (2024) 144 (Supplement 1): 1683.

https://doi.org/10.1182/blood-2024-205026

Published: 2024

NARROW

Gut Microbiome Composition As a Prognostic Marker in CD19-Targeting CAR T-Cell Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Real-World Outcomes of Polatuzumab Vedotin with Bendamustine and Rituximab As Salvage and Bridge Therapy to CAR T-Cell Treatment in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Long-Term Outcomes of Bronchus-Associated Lymphoid Tissue Lymphoma Based on Lung Involvement Status: A Single-Center Real-World Data Analysis in Korea

New Diagnostic Technology for the Isolation and Analysis of Live Myeloma Cell from the Blood of Multiple Myeloma Patients

Multicenter, Open-Label, Phase I Study of Azacitidine-CHOP for Patients with Nodal T-Cell Lymphoma with T-Follicular Helper Phenotype

Email alerts

ASH Publications

American Society of Hematology

Gut Microbiome Composition As a Prognostic Marker in CD19-Targeting CAR T-Cell Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Real-World Outcomes of Polatuzumab Vedotin with Bendamustine and Rituximab As Salvage and Bridge Therapy to CAR T-Cell Treatment in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Long-Term Outcomes of Bronchus-Associated Lymphoid Tissue Lymphoma Based on Lung Involvement Status: A Single-Center Real-World Data Analysis in Korea

New Diagnostic Technology for the Isolation and Analysis of Live Myeloma Cell from the Blood of Multiple Myeloma Patients

Multicenter, Open-Label, Phase I Study of Azacitidine-CHOP for Patients with Nodal T-Cell Lymphoma with T-Follicular Helper Phenotype

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only